December 2024 Recall: Topics in Autoimmune Neurology
Neurology® Podcast
00:00
Advancements in NMOSD Treatment
This chapter explores the latest developments in treating Neuromyelitis Optica Spectrum Disorders, focusing on the monoclonal antibody eculizumab and its role in inhibiting disease pathology. It discusses the balance between the effectiveness of new therapies and the associated risks, particularly concerning meningococcal vaccinations and relapse rates. The conversation also covers the transition from prior treatments, logistical challenges, and the introduction of new medications like rivolizumab to enhance patient outcomes.
Transcript
Play full episode
